Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial.

Cucchiara B, George DK, Kasner SE, Knutsson M, Denison H, Ladenvall P, Amarenco P, Johnston SC.

Neurology. 2019 Aug 13;93(7):e708-e716. doi: 10.1212/WNL.0000000000007936. Epub 2019 Jul 11.

PMID:
31296654
2.

A survey of knowledge, attitudes and awareness of the human papillomavirus among healthcare professionals across the UK.

Sherman SM, Cohen CR, Denison HJ, Bromhead C, Patel H.

Eur J Public Health. 2019 Jun 10. pii: ckz113. doi: 10.1093/eurpub/ckz113. [Epub ahead of print]

PMID:
31180488
3.

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.

Easton JD, Denison H, Evans SR, Knutsson M, Amarenco P, Albers GW, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KL, Johnston SC; SOCRATES Steering Committee and Investigators.

Int J Stroke. 2019 May 15:1747493019851282. doi: 10.1177/1747493019851282. [Epub ahead of print]

PMID:
31092152
4.

Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.

Molina CA, Johnston SC, Ladenvall P, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Knutsson M, Minematsu K, Röther J, Wang Y, Wong KSL; SOCRATES Steering Committee and Investigators.

Stroke. 2019 Mar;50(3):675-682. doi: 10.1161/STROKEAHA.118.022675. Erratum in: Stroke. 2019 Apr;50(4):e118.

PMID:
30776996
5.

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.

Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y; THALES Investigators.

Int J Stroke. 2019 Feb 12:1747493019830307. doi: 10.1177/1747493019830307. [Epub ahead of print]

PMID:
30747613
6.

Knowledge, attitudes and awareness of the human papillomavirus among health professionals in New Zealand.

Sherman SM, Bartholomew K, Denison HJ, Patel H, Moss EL, Douwes J, Bromhead C.

PLoS One. 2018 Dec 31;13(12):e0197648. doi: 10.1371/journal.pone.0197648. eCollection 2018.

7.

Healthcare-seeking behaviour of people with sexually transmitted infection symptoms attending a Sexual Health Clinic in New Zealand.

Denison HJ, Woods L, Bromhead C, Kennedy J, Grainger R, Jutel A, Dennison EM.

N Z Med J. 2018 Aug 31;131(1481):40-49.

8.

Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.

Wong KSL, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Himmelmann A, Kasner SE, Knutsson M, Ladenvall P, Minematsu K, Molina CA, Wang Y, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2018 Jul;49(7):1678-1685. doi: 10.1161/STROKEAHA.118.020553. Epub 2018 Jun 18.

9.

What influences university students to seek sexually transmitted infection testing?: A qualitative study in New Zealand.

Denison HJ, Bromhead C, Grainger R, Dennison EM, Jutel A.

Sex Reprod Healthc. 2018 Jun;16:56-60. doi: 10.1016/j.srhc.2018.01.004. Epub 2018 Jan 31.

10.

Inequities in exposure to occupational risk factors between Māori and non-Māori workers in Aotearoa New Zealand.

Denison HJ, Eng A, Barnes LA, Cheng S, 't Mannetje A, Haddock K, Douwes J, Pearce N, Ellison-Loschmann L.

J Epidemiol Community Health. 2018 Sep;72(9):809-816. doi: 10.1136/jech-2018-210438. Epub 2018 May 2.

PMID:
29720390
11.

Increasing rates of people identifying as transgender presenting to Endocrine Services in the Wellington region.

Delahunt JW, Denison HJ, Sim DA, Bullock JJ, Krebs JD.

N Z Med J. 2018 Jan 19;131(1468):33-42.

PMID:
29346355
12.

Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.

Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2017 Sep;48(9):2480-2487. doi: 10.1161/STROKEAHA.117.017217. Epub 2017 Jul 18.

PMID:
28720658
13.

Barriers to sexually transmitted infection testing in New Zealand: a qualitative study.

Denison HJ, Bromhead C, Grainger R, Dennison EM, Jutel A.

Aust N Z J Public Health. 2017 Aug;41(4):432-437. doi: 10.1111/1753-6405.12680. Epub 2017 Jun 29.

14.

Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).

Easton JD, Aunes M, Albers GW, Amarenco P, Bokelund-Singh S, Denison H, Evans SR, Held P, Jahreskog M, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Circulation. 2017 Sep 5;136(10):907-916. doi: 10.1161/CIRCULATIONAHA.117.028566. Epub 2017 Jun 27.

PMID:
28655834
15.

Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.

Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Lancet Neurol. 2017 Apr;16(4):301-310. doi: 10.1016/S1474-4422(17)30038-8. Epub 2017 Feb 23.

PMID:
28238711
16.

Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).

Wang Y, Minematsu K, Wong KS, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Molina CA, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2017 Jan;48(1):167-173. doi: 10.1161/STROKEAHA.116.014891. Epub 2016 Nov 29.

PMID:
27899747
17.

The incidence of sexually acquired reactive arthritis: a systematic literature review.

Denison HJ, Curtis EM, Clynes MA, Bromhead C, Dennison EM, Grainger R.

Clin Rheumatol. 2016 Nov;35(11):2639-2648. Epub 2016 Aug 1. Review.

18.

Specialist services for management of individuals identifying as transgender in New Zealand.

Delahunt JW, Denison HJ, Kennedy J, Hilton J, Young H, Chaudhri OB, Elston MS.

N Z Med J. 2016 May 6;129(1434):49-58.

PMID:
27349263
19.

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.

Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KS; SOCRATES Steering Committee and Investigators.

N Engl J Med. 2016 Jul 7;375(1):35-43. doi: 10.1056/NEJMoa1603060. Epub 2016 May 10.

20.

Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia.

Rydholm H, von Corswant C, Denison H, Jensen JM, Lehmann A, Ruth M, Söderlind E, Aurell-Holmberg A.

Clin Ther. 2016 Apr;38(4):946-60. doi: 10.1016/j.clinthera.2016.02.012. Review.

PMID:
26947796
21.

Non-invasive Assessment of Lower Limb Geometry and Strength Using Hip Structural Analysis and Peripheral Quantitative Computed Tomography: A Population-Based Comparison.

Litwic AE, Clynes M, Denison HJ, Jameson KA, Edwards MH, Sayer AA, Taylor P, Cooper C, Dennison EM.

Calcif Tissue Int. 2016 Feb;98(2):158-64. doi: 10.1007/s00223-015-0081-7. Epub 2015 Nov 21.

22.

Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease.

Vakil N, Niklasson A, Denison H, Rydén A.

United European Gastroenterol J. 2015 Oct;3(5):443-52. doi: 10.1177/2050640614558343.

23.

Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.

Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Held P, Jonasson J, Minematsu K, Molina CA, Wong LK.

Int J Stroke. 2015 Dec;10(8):1304-8. doi: 10.1111/ijs.12610. Epub 2015 Aug 26.

PMID:
26311628
24.

Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people.

Denison HJ, Cooper C, Sayer AA, Robinson SM.

Clin Interv Aging. 2015 May 11;10:859-69. doi: 10.2147/CIA.S55842. eCollection 2015. Review.

25.
26.

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need; authors' reply.

Kahrilas PJ, Persson T, Denison H, Wernersson B, Hughes N, Howden CW.

Aliment Pharmacol Ther. 2014 Oct;40(8):989. doi: 10.1111/apt.12943. No abstract available.

27.

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Kahrilas PJ, Persson T, Denison H, Wernersson B, Hughes N, Howden CW.

Aliment Pharmacol Ther. 2014 Sep;40(6):648-56. doi: 10.1111/apt.12877. Epub 2014 Jul 15.

28.

Peripheral quantitative computed tomography measures are associated with adult fracture risk: the Hertfordshire Cohort Study.

Dennison EM, Jameson KA, Edwards MH, Denison HJ, Aihie Sayer A, Cooper C.

Bone. 2014 Jul;64:13-7. doi: 10.1016/j.bone.2014.03.040. Epub 2014 Mar 27.

PMID:
24680720
29.

Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial.

Denison H, Nilsson C, Löfgren L, Himmelmann A, Mårtensson G, Knutsson M, Al-Shurbaji A, Tornqvist H, Eriksson JW.

Diabetes Obes Metab. 2014 Apr;16(4):334-43. doi: 10.1111/dom.12221. Epub 2013 Oct 31.

PMID:
24118885
30.

Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors.

Rydén A, Denison H, Karlsson M, Vakil N.

Scand J Gastroenterol. 2013 Sep;48(9):1018-26. doi: 10.3109/00365521.2013.822544. Epub 2013 Aug 6.

PMID:
23919738
31.

How to get started with a systematic review in epidemiology: an introductory guide for early career researchers.

Denison HJ, Dodds RM, Ntani G, Cooper R, Cooper C, Sayer AA, Baird J.

Arch Public Health. 2013 Aug 7;71(1):21. doi: 10.1186/0778-7367-71-21.

32.

Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.

Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW.

Gut. 2014 May;63(5):720-6. doi: 10.1136/gutjnl-2013-304883. Epub 2013 Jul 5.

33.

Effects of aerobic exercise on muscle strength and physical performance in community-dwelling older people from the Hertfordshire cohort study: a randomized controlled trial.

Denison HJ, Syddall HE, Dodds R, Martin HJ, Finucane FM, Griffin SJ, Wareham NJ, Cooper C, Sayer AA.

J Am Geriatr Soc. 2013 Jun;61(6):1034-6. doi: 10.1111/jgs.12286. No abstract available.

34.

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.

Kahrilas PJ, Howden CW, Wernersson B, Denison H, Nuevo J, Gisbert JP.

Aliment Pharmacol Ther. 2013 May;37(10):1005-10. doi: 10.1111/apt.12298. Epub 2013 Apr 5.

35.

Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS).

Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, Edwards M, Dennison E, Cooper C, Aihie Sayer A.

Age Ageing. 2013 May;42(3):378-84. doi: 10.1093/ageing/afs197. Epub 2013 Feb 5.

36.

The importance of fall history in fracture risk assessment.

Edwards MH, Jameson KA, Denison H, Harvey NC, Sayer AA, Dennison EM, Cooper C.

Bone. 2013 Apr;53(2):598. doi: 10.1016/j.bone.2013.01.030. Epub 2013 Jan 24. No abstract available.

37.

Esophageal mucosal breaks in gastroesophageal reflux disease partially responsive to proton pump inhibitor therapy.

Shaheen NJ, Denison H, Björck K, Silberg DG.

Am J Gastroenterol. 2013 Apr;108(4):529-34. doi: 10.1038/ajg.2012.447. Epub 2013 Jan 15.

PMID:
23318482
38.

The Framingham Heart Study clock drawing performance: normative data from the offspring cohort.

Nyborn JA, Himali JJ, Beiser AS, Devine SA, Du Y, Kaplan E, O'Connor MK, Rinn WE, Denison HS, Seshadri S, Wolf PA, Au R.

Exp Aging Res. 2013;39(1):80-108. doi: 10.1080/0361073X.2013.741996.

39.

Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy.

Vakil N, Björck K, Denison H, Halling K, Karlsson M, Paty J, Silberg DG, Rydén A.

Clin Transl Gastroenterol. 2012 Jan 26;3:e7. doi: 10.1038/ctg.2012.1.

40.

Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women.

Edwards MH, Jameson K, Denison H, Harvey NC, Sayer AA, Dennison EM, Cooper C.

Bone. 2013 Feb;52(2):541-7. doi: 10.1016/j.bone.2012.11.006. Epub 2012 Nov 13.

41.

Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study.

Denison H, Nilsson C, Kujacic M, Löfgren L, Karlsson C, Knutsson M, Eriksson JW.

Diabetes Obes Metab. 2013 Feb;15(2):136-43. doi: 10.1111/dom.12002. Epub 2012 Sep 30.

PMID:
22950654
42.

Birth weight and muscle strength: a systematic review and meta-analysis.

Dodds R, Denison HJ, Ntani G, Cooper R, Cooper C, Sayer AA, Baird J.

J Nutr Health Aging. 2012 Jul;16(7):609-15. Review.

43.

Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.

Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW.

Am J Gastroenterol. 2012 Sep;107(9):1354-60. doi: 10.1038/ajg.2012.197. Epub 2012 Jul 10.

PMID:
22777339
44.

Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial.

Shaheen NJ, Denison H, Björck K, Karlsson M, Silberg DG.

Gut. 2013 Sep;62(9):1248-55. doi: 10.1136/gutjnl-2012-302737. Epub 2012 Jun 23.

PMID:
22730470
45.

Patterns of dietary supplement use among older men and women in the UK: findings from the Hertfordshire Cohort Study.

Denison HJ, Jameson KA, Syddall HE, Dennison EM, Cooper C, Sayer AA, Robinson SM.

J Nutr Health Aging. 2012 Apr;16(4):307-11.

PMID:
22499447
46.

The Hertfordshire Cohort Study: from historical to high-tech studies of musculoskeletal ageing in men and women entering their ninth decade.

Denison HJ, Simmonds SJ, Syddall HE, Robinson SM, Dennison EM, Cooper C, Sayer AA; Hertfordshire Cohort Study Group.

Int J Epidemiol. 2012 Apr;41(2):386-9. doi: 10.1093/ije/dys019. No abstract available.

47.

Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.

Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW.

Clin Gastroenterol Hepatol. 2012 Jun;10(6):612-9. doi: 10.1016/j.cgh.2012.01.022. Epub 2012 Feb 14.

PMID:
22343515
48.

Translational gastrointestinal pharmacology in the 21st century: 'the lesogaberan story'.

Boeckxstaens GE, Denison H, Jensen JM, Lehmann A, Ruth M.

Curr Opin Pharmacol. 2011 Dec;11(6):630-3. doi: 10.1016/j.coph.2011.10.011. Epub 2011 Oct 27. Review.

PMID:
22036168
49.

A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach.

Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, Sayer AA.

Age Ageing. 2011 Jul;40(4):423-9. doi: 10.1093/ageing/afr051. Epub 2011 May 30. Review.

PMID:
21624928
50.

A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.

Boeckxstaens GE, Beaumont H, Hatlebakk JG, Silberg DG, Björck K, Karlsson M, Denison H.

Gut. 2011 Sep;60(9):1182-8. doi: 10.1136/gut.2010.235630. Epub 2011 Mar 14.

PMID:
21402616

Supplemental Content

Loading ...
Support Center